Hollak CE - Search Results

1

Chloroquine-induced phospholipidosis of the kidney mimicking Fabry's disease.

Linthorst GE, Hollak CE. Linthorst GE, et al. Among authors: hollak ce. Hum Pathol. 2003 Dec;34(12):1358; author reply 1358-9. doi: 10.1016/s0046-8177(03)00396-4. Hum Pathol. 2003. PMID: 14691926 No abstract available.

2

Immune response to enzyme replacement therapy in Fabry disease: impact on clinical outcome?

Hollak CE, Linthorst GE. Hollak CE, et al. Mol Genet Metab. 2009 Jan;96(1):1-3. doi: 10.1016/j.ymgme.2008.10.013. Epub 2008 Dec 4. Mol Genet Metab. 2009. PMID: 19062323 No abstract available.

3

Screening for Fabry disease in high-risk populations: a systematic review.

Linthorst GE, Bouwman MG, Wijburg FA, Aerts JM, Poorthuis BJ, Hollak CE. Linthorst GE, et al. Among authors: hollak ce. J Med Genet. 2010 Apr;47(4):217-22. doi: 10.1136/jmg.2009.072116. Epub 2009 Sep 24. J Med Genet. 2010. PMID: 19797197 Review.

4

Enzyme replacement in Anderson-Fabry disease.

Bengtsson BA, Johansson JO, Hollak C, Linthorst G, FeldtRasmussen U. Bengtsson BA, et al. Lancet. 2003 Jan 25;361(9354):352. doi: 10.1016/S0140-6736(03)12357-4. Lancet. 2003. PMID: 12559898 No abstract available.

5

Novel therapeutic targets for the treatment of Fabry disease.

Hollak CE, Vedder AC, Linthorst GE, Aerts JM. Hollak CE, et al. Expert Opin Ther Targets. 2007 Jun;11(6):821-33. doi: 10.1517/14728222.11.6.821. Expert Opin Ther Targets. 2007. PMID: 17504019 Review.

6

Enzyme activity for determination of presence of Fabry disease in women results in 40% false-negative results.

Linthorst GE, Poorthuis BJ, Hollak CE. Linthorst GE, et al. Among authors: hollak ce. J Am Coll Cardiol. 2008 May 27;51(21):2082; author reply 2082-3. doi: 10.1016/j.jacc.2008.02.050. J Am Coll Cardiol. 2008. PMID: 18498967 Free article. No abstract available.

7

[Fabry's disease; towards a treatment].

Linthorst GE, Hollak CE, Bosman DK, Heymans HS, Aerts JM. Linthorst GE, et al. Among authors: hollak ce. Ned Tijdschr Geneeskd. 2000 Dec 9;144(50):2391-5. Ned Tijdschr Geneeskd. 2000. PMID: 11145093 Review. Dutch.

8

Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis.

van der Tol L, Svarstad E, Ortiz A, Tøndel C, Oliveira JP, Vogt L, Waldek S, Hughes DA, Lachmann RH, Terryn W, Hollak CE, Florquin S, van den Bergh Weerman MA, Wanner C, West ML, Biegstraaten M, Linthorst GE. van der Tol L, et al. Among authors: hollak ce. Mol Genet Metab. 2015 Feb;114(2):242-7. doi: 10.1016/j.ymgme.2014.08.007. Epub 2014 Aug 20. Mol Genet Metab. 2015. PMID: 25187469

9

Misdiagnosis of Fabry disease: importance of biochemical confirmation of clinical or pathological suspicion.

Linthorst GE, De Rie MA, Tjiam KH, Aerts JM, Dingemans KP, Hollak CE. Linthorst GE, et al. Among authors: hollak ce. Br J Dermatol. 2004 Mar;150(3):575-7. doi: 10.1046/j.1365-2133.2004.05813.x. Br J Dermatol. 2004. PMID: 15030345

10

Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy.

Vedder AC, Cox-Brinkman J, Hollak CE, Linthorst GE, Groener JE, Helmond MT, Scheij S, Aerts JM. Vedder AC, et al. Among authors: hollak ce. Mol Genet Metab. 2006 Nov;89(3):239-44. doi: 10.1016/j.ymgme.2006.04.013. Epub 2006 Jun 9. Mol Genet Metab. 2006. PMID: 16765076 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

313 results

Search Page